Skip to main content
. 2015 Feb 22;37:e2015010. doi: 10.4178/epih/e2015010

Figure 1.

Figure 1.

Cost-effectiveness analysis model. ATR, atorvastatin; AML, amlodipine; LDL-C, low density lipoprotein cholesterol.